0
Industry
Geography
Report Type
Themes
Price
Publication date
Published Date
  • Product Insights

    New
    $3,500 | June 2024
    Product Insights
    New

    CD276 Antigen – Drugs In Development, 2024

    The CD276 Antigen pipeline drugs market research report outlays comprehensive information on the CD276 Antigen targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology which include indications of Solid Tumor, and Unspecified Cancer. It also reviews key players involved in CD276 Antigen targeted therapeutics development with respective active and dormant or discontinued projects. Note: * This is...

  • Product Insights

    New
    $3,500 | June 2024
    Product Insights
    New

    Poliovirus Receptor – Drugs In Development, 2024

    The Poliovirus Receptor pipeline drugs market research report outlays comprehensive information on the Poliovirus Receptor targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology which include indications of Unspecified Cancer, and Solid Tumor. It also reviews key players involved in Poliovirus Receptor targeted therapeutics development with respective active and dormant or discontinued projects. Note: * This is...

  • Product Insights

    New
    $3,500 | June 2024
    Product Insights
    New

    Angiotensinogen – Drugs In Development, 2024

    The Angiotensinogen pipeline drugs market research report outlays comprehensive information on the Angiotensinogen targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Cardiovascular, and Metabolic Disorders which include indications of Hypertension, Resistant Hypertension, and Hypertriglyceridemia. It also reviews key players involved in Angiotensinogen targeted therapeutics development with respective active and dormant or discontinued projects. Note: * This is...

  • Product Insights

    New
    $3,500 | June 2024
    Product Insights
    New

    Frataxin Mitochondrial – Drugs In Development, 2024

    The Frataxin Mitochondrial pipeline drugs market research report outlays comprehensive information on the Frataxin Mitochondrial targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Central Nervous System, and Cardiovascular which include indications of Friedreich Ataxia, and Cardiomyopathy. It also reviews key players involved in Frataxin Mitochondrial targeted therapeutics development with respective active and dormant or discontinued projects. Note:...

  • Product Insights

    New
    $3,500 | June 2024
    Product Insights
    New

    NS5B – Drugs In Development, 2024

    The NS5B pipeline drugs market research report outlays comprehensive information on the NS5B targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Infectious Disease which include indications of Hepatitis C, and Coronavirus Disease 2019 (COVID-19). It also reviews key players involved in NS5B targeted therapeutics development with respective active and dormant or discontinued projects. Note: * This is...

  • Product Insights

    New
    $3,500 | June 2024
    Product Insights
    New

    Phenylalanine 4 Hydroxylase – Drugs In Development, 2024

    The Phenylalanine 4 Hydroxylase pipeline drugs market research report outlays comprehensive information on the Phenylalanine 4 Hydroxylase targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Metabolic Disorders which include indications of Phenylketonuria (PKU). It also reviews key players involved in Phenylalanine 4 Hydroxylase targeted therapeutics development with respective active and dormant or discontinued projects. Note: * This...

  • Product Insights

    New
    $3,500 | June 2024
    Product Insights
    New

    Myotonin Protein Kinase – Drugs In Development, 2024

    The Myotonin Protein Kinase pipeline drugs market research report outlays comprehensive information on the Myotonin Protein Kinase targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Musculoskeletal Disorders which include indications of Myotonic Dystrophy. It also reviews key players involved in Myotonin Protein Kinase targeted therapeutics development with respective active and dormant or discontinued projects. Note: * This...

  • Product Insights

    New
    $3,500 | June 2024
    Product Insights
    New

    Claudin 18 – Drugs In Development, 2024

    The Claudin 18 pipeline drugs market research report outlays comprehensive information on the Claudin 18 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, and Undisclosed which include indications of Gastric Cancer, Solid Tumor, and Unspecified. It also reviews key players involved in Claudin 18 targeted therapeutics development with respective active and dormant or discontinued projects. Note:...

  • Product Insights

    New
    $3,500 | June 2024
    Product Insights
    New

    Glypican 3 – Drugs In Development, 2024

    The Glypican 3 pipeline drugs market research report outlays comprehensive information on the Glypican 3 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology which include indications of Hepatocellular Carcinoma, and Solid Tumor. It also reviews key players involved in Glypican 3 targeted therapeutics development with respective active and dormant or discontinued projects. Note: * This is...

  • Product Insights

    New
    $3,500 | June 2024
    Product Insights
    New

    Cholinesterase – Drugs In Development, 2024

    The Cholinesterase pipeline drugs market research report outlays comprehensive information on the Cholinesterase targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Central Nervous System, and Cardiovascular which include indications of Alzheimer's Disease, Dementia, and Ischemic Stroke. It also reviews key players involved in Cholinesterase targeted therapeutics development with respective active and dormant or discontinued projects. Note: *...

Looking to stay on top of industry & market trends?

Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.